Tag: AAAAI Annual Meeting

acalabrutinib

Cancer Drug Shows Promise as Treatment for Food Allergies

A study published in the Journal of Allergy and Clinical Immunology shows acalabrutinib, a BTK inhibitor, can reduce and prevent allergic reactions to peanuts...
Aquestive's AQST-109

Sublingual Epinephrine Faster to Maximum Concentration than Auto-Injector, Syringe

Researchers observed early and robust increases in systolic and diastolic blood pressure and pulse with AQST-109.
Garlic

Garlic Allergy More Common and Dangerous Than Suspected

"I ended up in the hospital because of this reaction."
Anxious Traveler

1-in-3 Air Travelers with Food Allergies Choose Not to Disclose Fact...

98% reported increased anxiety while traveling due to food allergies.
Revolo Biotherapeutics '1104

Peptide Shows Promise as an Allergen-Agnostic Treatment for Food Allergy

Revolog presents new data demonstrating long-lasting effect of '1104 candidate.
Bryn Pharma Intranasal Epinephrine Device

Bryn Shows UTULY™ Intranasal Epinephrine Absorbs Faster and is Sustained Longer...

A needleless, self administered nasal spray intended to be used in anaphylactic emergencies in place of traditional auto-injectors.
ADHD

Allergy in Early Childhood Increases Risk for ADHD Later in Life

The retrospective study analyzed the records of over 230,000 children.
Skin Prick Testing

Study Finds Majority Learn of Their Sesame Allergy After Diagnosis of...

Only 1/3 of patients had prior reaction to sesame.
Aquestive's Subingual Epinephrine

Aquestive’s Sublingual Epinephrine Achieves Therapeutic Blood Concentrations Following Administration

Company presented top level Phase 1 results at #AAAAI2022 meeting.
Intranasal Spray

Intranasal Epinephrine to Take Center Stage at 2022 AAAAI Annual Meeting

Emergency epinephrine without the jab makes strides.